Get the Stockscreener App
0.21
0.96%
0.002
After Hours:
.20
-0.010
-4.76%
China Pharma Holdings Inc. stock is traded at $0.21, with a volume of 231.20K.
It is up +0.96% in the last 24 hours and up +9.20% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$0.208
Open:
$0.202
24h Volume:
231.20K
Relative Volume:
0.31
Market Cap:
$4.04M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-0.625
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
-4.50%
1M Performance:
+9.20%
6M Performance:
-20.75%
1Y Performance:
-56.43%
1-Day Range:
$0.2001
$0.2139
1-Week Range:
$0.194
$0.2388
52-Week Range:
$0.13
$0.599
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.21 | 4.04M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
165.89 | 74.84B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.92 | 40.96B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.92 | 24.83B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
143.26 | 14.50B | 2.24B | 385.90M | 440.10M | 3.73 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World
China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World
Dry Eye Products Market Opportunities and Strategies to - GlobeNewswire
Layoff Tracker: Regeneron Acquisition of Oxular Wipes Out Oxular Workforce - BioSpace
Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million - MSN
Barclays PLC Has $759,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World
StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World
China Pharma Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com
China Pharma Holdings, Inc. Rescinds Securities Purchase Agreement - Defense World
PetVivo Holdings, Inc. to Make Investor Presentations - Defense World
Keen Vision Acquisition Extends Business Combination PeriodKeen Vision Acquisition Corporation (NASDAQ: KVAC) has recently filed a Form 8-K with the Securities and Exchange Commission, announcing the extension of its business combination period. T - Defense World
AmpliTech Group Enters Securities Purchase Agreement with Institutional InvestorsWASHINGTON, D.C., December 24, 2024 – AmpliTech Group, Inc. (NASDAQ: AMPG) disclosed today in an 8-K filing with the Securities and Exchange Commission that it has - Defense World
Blackboxstocks Inc. Dismisses Turner, Stone & Company as Independent Registered Public Accounting Firm; Engages Victor Mokuolo CPA PLLC as ReplacementOn December 20, 2024, Blackboxstocks Inc. (NASDAQ: BLBX) made significant changes in its a - Defense World
The Glimpse Group Announces Closing of $7.29 Million OfferingWASHINGTON, D.C., December 23, 2024 – The Glimpse Group, Inc. (NASDAQ:VRAR) disclosed the finalization of a registered direct offering on December 23, 2024. The undertaking involved a - Defense World
Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World
Analysts Set Celsius Holdings, Inc. (NASDAQ:CELH) Price Target at $50.28 - Defense World
China Pharma Holdings, Inc. Successfully Conducts Annual Stockholders’ Meeting - Defense World
GlycoMimetics Receives Extension Notice from Nasdaq Regarding Minimum Bid Price ComplianceOn December 19, 2024, GlycoMimetics, Inc. (NASDAQ: GLYC) disclosed in an 8-K filing with the Securities and Exchange Commission that it had received an e - Defense World
**Rhinebeck Bancorp Completes Balance Sheet Repositioning, Projects Earnings Growth** - Defense World
Wrap Technologies Reports Approval of Incentive Plan Amendment and Director Elections at Annual Meeting - Defense World
Financial Review: Autozi Internet Technology (Global) (NASDAQ:AZI) vs. Driven Brands (NASDAQ:DRVN) - Defense World
Aker BP ASA (OTCMKTS:AKRBF) Trading Down 1.7% – Here’s What Happened - Defense World
Edesa Biotech, Inc. (NASDAQ:EDSA) Short Interest Update - Defense World
Financial Survey: Flagstar Financial (FLG) and Its Peers - Defense World
White Gold Corp. (OTCMKTS:WHGOF) Short Interest Down 99.3% in December - Defense World
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World
HighTower Advisors LLC Grows Holdings in American Century STOXX U.S. Quality Growth ETF (NYSEARCA:QGRO) - Defense World
Items Tagged with 'Jeil Pharma Holdings Inc.' - BioWorld Online
Hengrui Pharma accelerates bid for global brand status - Bamboo Works
China Pharma settles convertible note obligations By Investing.com - Investing.com Australia
China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville - Citizentribune
China Pharma settles convertible note obligations - Investing.com
China Pharma (CPHI) Strengthens Balance Sheet with Early $5.25M Convertible Note Redemption - StockTitan
Merck enters obesity drug race in pact with Chinese pharma Hansoh - Seeking Alpha
Act Fast and You Can Still Enroll In An ACA Healthcare Plan for 2025 - 69News WFMZ-TV
With Correct Measurements, Wine Really May Protect Heart - 69News WFMZ-TV
Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist - Yahoo Finance
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights - Yahoo Finance
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World
U.S. Energy Enters Purchase and Sale Agreement with 84 Resources Holdings: Date of Agreement December 12, 2024 - Defense World
Werner Enterprises, Inc. (NASDAQ:WERN) Given Average Recommendation of “Reduce” by Brokerages - Defense World
NewAmsterdam Pharma (NASDAQ:NAMS) Enters into Underwriting Agreement for Public OfferingNEW YORK–(BUSINESS WIRE)– December 13, 2024– NewAmsterdam Pharma Company N.V. (NAMS) announced today the completion of an underwritten pub - Defense World
Reviva Pharmaceuticals Holdings, Inc. Holds Annual Meeting and Approves Increase in Authorized Shares - Defense World
Lloyds Banking Group plc (LON:LLOY) Given Average Recommendation of “Hold” by Brokerages - Defense World
Worksport Ltd. Shares Latest Corporate Updates, Crypto Investment Approaches as Market Position Strengthens - Defense World
Kimco Realty Corporation (KIM) Announces Final Results of Tender Offer and Consent Solicitation - Defense World
3D Systems Enters Agreement to Sell Geomagic Software Portfolio - Defense World
At The Market Sales Agreement: MediaCo Holding Inc. Enters Agreement with BTIG, LLC and Moelis & Company LLC - Defense World
Hub Group, Inc. (NASDAQ:HUBG) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):